Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:SYN
DataHoraFonteTítuloCódigoCompanhia
27/06/202318:11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
08/06/202308:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
11/05/202309:17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
30/03/202309:18Edgar (US Regulatory)Annual Report (10-k)AMEX:SYNSynthetic Biologics Inc
09/12/202208:04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:SYNSynthetic Biologics Inc
05/12/202218:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:SYNSynthetic Biologics Inc
29/09/202208:25TipRanksMaxim Group Sticks to Its Buy Rating for Synthetic Biologics (SYN)AMEX:SYNSynthetic Biologics Inc
16/09/202217:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
06/09/202217:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:SYNSynthetic Biologics Inc
16/08/202218:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:SYNSynthetic Biologics Inc
11/08/202210:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:SYNSynthetic Biologics Inc
04/08/202207:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:SYNSynthetic Biologics Inc
17/05/202212:45TipRanksMaxim Group Thinks Synthetic Biologics’ Stock is Going to RecoverAMEX:SYNSynthetic Biologics Inc
23/02/202218:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:SYNSynthetic Biologics Inc
09/02/202209:15PR Newswire (US)Synthetic Biologics to Present at 2022 BIO CEO & Investor ConferenceAMEX:SYNSynthetic Biologics Inc
08/02/202209:15PR Newswire (US)Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDAAMEX:SYNSynthetic Biologics Inc
26/01/202218:05PR Newswire (US)Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022AMEX:SYNSynthetic Biologics Inc
14/12/202109:00PR Newswire (US)Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid TumorsAMEX:SYNSynthetic Biologics Inc
03/11/202117:10PR Newswire (US)Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
26/10/202108:00PR Newswire (US)Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021AMEX:SYNSynthetic Biologics Inc
22/10/202118:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:SYNSynthetic Biologics Inc
21/10/202108:00PR Newswire (US)Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline PhosphataseAMEX:SYNSynthetic Biologics Inc
06/10/202117:36PR Newswire (US)Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
21/09/202117:30PR Newswire (US)Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
25/08/202117:31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:SYNSynthetic Biologics Inc
05/08/202117:10PR Newswire (US)Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
03/08/202118:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:SYNSynthetic Biologics Inc
03/08/202108:00PR Newswire (US)Synthetic Biologics Expands Option for an Exclusive License Agreement with Massachusetts General HospitalAMEX:SYNSynthetic Biologics Inc
28/07/202108:00PR Newswire (US)Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021AMEX:SYNSynthetic Biologics Inc
29/06/202108:00PR Newswire (US)Synthetic Biologics Provides Update on SYN-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical TrialAMEX:SYNSynthetic Biologics Inc
 Apresentando as notícias mais relevantes sobre:AMEX:SYN